Impairment

2

Review clinical trials related to Impairment. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

An Ecological Momentary Intervention for the Reduction of Impairment in Somatic Symptom Disorder

Persistent somatic symptoms significantly impair the daily lives of individuals with Somatic Symptom Disorder (SSD). Negative psychological factors (NPFs), such as catastrophizing and negative affectivity, further compound this impairment. Yet, few studies have examined strategies in daily life that directly target somatic symptoms and their dynamic relationship with NPFs. The goal of this clinical trial is to investigate if an Ecological Momentary Intervention (EMI) using music listening and cognitive reappraisal can reduce the intensity of and impairment due to somatic symptoms in 40 individuals with Somatic Symptom Disorder (SSD), aged 18-65 years. Participants will report symptom intensity, impairment, and NPFs up to four times daily via a smartphone app over a six-week period. Using an intraindividual randomized controlled design, during weeks two to five, participants will be randomly assigned in the ratio of 50:25:25 to no intervention, music listening, and cognitive reappraisal, both at fixed times (evening measurement) and during episodes of acute somatic impairment.

Participants needed: 40
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: University of ViennaUpdated: Jun 12, 2026Locations: 1
Eligibility criteria

Somatic Symptom Disorder

chronic physical illnesses that fully explain the somatic symptoms [+6]

Status: Not yet recruiting

Evaluation of Oral THC and CBD in Men and Women

The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of oral delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.

Participants needed: 22
Trial details
Phase: Phase 1Age: 21-55Biological sex: AllType: InterventionalSponsor: University of California, Los AngelesUpdated: Jun 11, 2026Locations: 1
Eligibility criteria

Male or non-pregnant and non-lactating females aged 21-55 years [+5]

Meeting DSM-V criteria for moderate to severe Cannabis Use disorder (CUD) or any... [+10]